Mr. Pedro Antonio Regidor | Medizin Und Gutartige Erkrankungen | Best Researcher Award
PD Dr. med, Exeltis Healthcare, Germany.
Prof. Dr. Pedro Antonio Regidor is a distinguished medical professional with dual German and Spanish citizenship, born on January 5, 1964, in Madrid, Spain. He completed his medical studies at the University of Essen and gained extensive experience in gynecology and obstetrics across Germany and Venezuela. Currently, he serves as the Head of the Department of Gynecology and Obstetrics at Frauenklinik München West in Munich, Germany. Prof. Dr. Regidor holds specialized certifications in radiological diagnostics and gynecological endocrinology. His contributions to women’s health and medical innovation have earned him recognition in the medical community ¹.
Professional Profile
orcid
Education
Medical Degree: University of Essen, Germany (1991) – Specialist for Gynecology and Obstetrics: since 1995 – Specialist for Gynecological Endocrinology and Reproductive Medicine: – Specialist for Gynecological Oncology: – Doctorate in Medicine (Dr. med.): University of Essen, Germany (1992) – Habilitation: University of Essen, Germany (2000)
Experience
Head of Department of Gynecology and Obstetrics: Frauenklinik München West, Munich, Germany – Medical Director: Exeltis Europe and Global Projects – Senior Physician: Various medical centers in Germany – Consultant: Lipocine Inc., USA (female hormone replacement therapy)
Research Focus
Prof. Dr. Regidor’s research focuses on advancing medical practice and patient care in gynecology and obstetrics. His work includes ¹: – Gynecological Endocrinology: Hormone replacement therapy and reproductive medicine – Gynecological Oncology: Cancer treatment and management – Women’s Health: Improving healthcare outcomes for women
Awards and Honors
Prof. Dr. Regidor’s career is marked by several significant recognitions, including his certifications in specialized fields such as radiological diagnostics and gynecological endocrinology. His role as a Medical Director involved overseeing global projects, indicating a strong track record of managing and implementing innovative solutions across diverse healthcare settings ¹.
Publication Top Notes
1. “The drospirenone only pill as a contraceptive option for breastfeeding women: First data on users’ acceptability and newborn development”
2. “OPEN PROSPECTIVE STUDY TO EVALUATE THE EFFICACY OF A NEW VAGINAL PESSARY CONTAINING 300MG TINIDAZOLE, 200MG TIOCONAZOLE AND 100MG LIDOCAINE”
3. “Nausea and Vomiting of Pregnancy and its Management with the Dual-Release Formulation of Doxylamine and Pyridoxine”
4. “Antibiotic prophylaxis in cesarean section — piperacillin versus piperacillin/tazobactam in 300 cesarean sections”
5. “Cyr61, a deregulated gene in endometriosis”